logo.gif (2253 bytes)



Home Page

Welcome

Committees

Sponsors

Advance Program

Posters Sessions:

General
Information

Pre and Post Congress Tours

Registered Accompanying Persons Program

Accommodation

Accommodation and Tour Form

Registration Form

 

ADVANCE PROGRAM - Poster Session

THURSDAY, OCTOBER 5, 2000

08:30 - 12:30 

Poster Hall

Board No.  
P411:  PHARMACOTHERAPY
EFFECT OF LONG-ACTING NIFEDIPINE ON THE INCIDENCE OF CARDIAC EVENTS IN POST-MYOCARDIAL INFARCTION PATIENTS
T. Hayashi, T. Taniwa, A. Kimura, M. Miyataka, A. Ikeda, H. Yabushita, T. Katayama, Osakasayama, Japan
ECCENTRIC DOSING OF NITRATES DOES NOT INCREASE, BUT IS NOT EFFECTIVE TO PREVENT THE CARDIAC DEATH IN HEALED MYOCARDIAL INFARCTION
K. Kanamasa, T. Hayashi, T. Takenaka, M. Miyataka, A. Kimura, T. Taniwa, A. Ikeda, K. Ishikawa, Osakasayama, Japan
SARPOGRELATE, A SEROTONIN BLOCKER, FOR THE TREATMENT OF EFFORT ANGINA: RESULTS OF RECENT CLINICAL TRIALS
T. Kinugawa, M. Fujita, J-D. Lee, H. Nakajima, H. Hanada, Yonago, Japan
THE LOCAL EFFECTS OF TRANSDERMAL NITROGLYCERIN TREATMENT IN PERIPHERAL VASCULARY PATHOLOGY AND IN OTHER VARIOUS DISEASES
G.G. Lupescu, R. Lupescu, C.C. Plavat, Tg Jiu, Romania
DIFFERENCES IN UTILIZATION OF EVIDENCE-BASED CARDIAC MEDICATION IN GERIATRIC PATIENTS
N.J. Mehta, New York NY, USA
THE USEFULLNESS OF MAGNESIUM SALTS IN THE MANAGEMENT OF PAROXYSMAL REENTRANT SUPRAVENTRICULAR TACHYCARDIA
S. Myftiu, V. Paparisto, A. Kondili, Tirana, Albania
A CHAIN OF COMPLICATIONS DUE TO TREATMENT WITH ANTIPLATELET DRUGS - WHERE DOES IT LEAD?
M. Berman, N. Pancheva, C. Yosefy, V. Khalameizer, L.H. Reisin, Ashkelon, Israel
THE ANTIARRYTHMIC EFFECTS OF SUBLINGUAL DITIAZEM FOR THE TREATMENT OF RECENT ATRIAL FIBRILLATION
A. Kondili, E. Hasani, M. Lezha, I. Bella, Tirana, Albania
STENT SUPPORTED CAROTID ARTERY ANGIOPLASTY. IS CEREBRAL PROTECTION NECESSARY?
M. Henry, C. Klonaris, M. Amor, I. Henry, S. Kownator, F. Luizy, B. Foliguet, K. Tzvetanov, Nancy, France
10  LOW MOLECULAR WEIGHT HEPARIN VERSUS REGULAR UNFRACTIONATED HEPARIN IN REDUCING THE RECURRENCE OF ISCHEMIC EVENTS DURING THE ACUTE PHASE OF UNSTABLE ANGINA
L.O. Yaneza, A. Pascual, A.U. Medina, M.B.A. Balagapo, Quezon City, Philippines
11  INCIDENCE OF THROMBOCYTOPENIA WITH THE USE OF GLYCOPROTEIN IIb/IIIa INHIBITORS IN REAL WORLD
M. Hashem, A. Ali, A. Rehan, T. Schreiber, N. Vikraman, T. LaLonde, M. Abed, J. Michael, R. Nugaram, D. Peiper, L. Moser, Detroit, MI, USA
P412:  CARDIAC SURGERY III
12  GASEOUS EMBOLI DURING CARDIOPULMONARY BYPASS: ASSOCIATION WITH COGNITIVE IMPAIRMENT
M.A. Borger, C.M. Peniston, R.D. Weisel, R.E.A. Green, M. Vasiliou, C.M. Feindel, Toronto ON, Canada
13  MINIMALLY INVASIVE, SIMPLE, NON-ENDOSCOPIC TECHNIQUE FOR SAPHENOUS VEIN HARVESTING
A. Borowski, Cologne, Germany
14  A NEW STRATEGY FOR ANTICOAGULATION OF PATIENTS WITH HIT AND IMPAIRED RENAL FUNCTION DURING CPB
A. Koster, R. Hetzer, H. Kuppe, M. Kukucka, Berlin, Germany
15  INFLUENCE OF DIFFERENT AUTOTRANSFUSION DEVICES ON THE QUALITY OF SALVAGED BLOOD
W. Reents, J. Babin-Ebell, M. Misoph, A. Weigl, A. Schwarzkof, O. Ekert, Wuerzburg, Germany
16  FATIGUE TESTING MEDIAN STERNOTOMY CLOSURES
A.R. Casha, M. Gauci, L. Yang, M. Saleh, G.J. Cooper, Leeds, UK
17  MID-TERM ENDOTHELIAL FUNCTION AND REMODELING OF RADIAL ARTERY GRAFTS
M. Gaudino, F. Glieca, N. Luciani, G. Possati, Rome, Italy
18  COAGULOFIBRINOLYSIS DURING HEPARIN-COATED CARDIOPULMONARY BYPASS WITH REDUCED HEPARINIZATION
H. Kumano, S. Suehiro, K. Hattori, T. Shibata, Y. Sasaki, M. Hosono, H. Kinoshita, Osaka, Japan
19  IS THE SIMULTANEOUS BILATERAL CAROTID ENDARTERECTOMY AN ACCEPTABLE PROCEDURE?
K. Katsenis, B. Arapoglou, A. Papageorgious, P. Dimakakos, Athens, Greece
20  PACEMAKER LEADS: A SIMPLE ATRAUMATIC METHOD FOR REPLACING PACEMAKER ELECTRODES
S. Steinberg, D. Mayer, New York NY, USA
21  OPTIMAL PERFUSION CONDITION DURING DEEP HYPOTHERMIC SURGERY
T. Watanabe, K. Inui, T. Minowa, J. Hosaka, T. Takahashi, Y. Shimazaki, Yamagata-City, Japan
57  AORTIC VALVE DISEASE ASSOCIATED WITH MITRAL INSUFFICIENCY-SURGICAL TREATMENT
W. Sarnowski, A. Ponizynski, Z. Oko-Sarnowska, M. Misterski, Z. Trojnarska, W. Dyszkiewicz, Poznan, Poland
P413:  CORONARY CIRCULATION
22  NEAR WALL VISCOSITY DISTRIBUTION BETWEEN INNER AND OUTER RIGHT CORONARY ARTERY WALL
G.D. Giannoglou, J.V. Soulis, T.M. Farmakis, D.M. Farmakis, G.E. Louridas, Thessaloniki, Greece
23  PROSTAGLANDINE INDUCE NEOVASCULARIZATION IN PATIENTS WITH THERAPY REFRACTORY ISCHEMIC HEART DISEASE
M.R. Mehrabi, T. Wild, C. Ekmekcioglu, N. Serbecic, K. Wild, F. Tamaddon, R. Seitelberger, Vienna, Austria
24  PROTAMINE INDUCES VASORELAXATION OF HUMAN INTERNAL THORACIC ARTERY BY ENDOTHELIAL NO-SYNTHASE PATHWAY
D. Pevni, I. Frolkis, I. Shapira, J. Gurevich, J. Paz, A. Kramer, C. Locker, G. Keren, R. Mohr, Tel-Aviv, Israel
25  MYOCARDIAL FRACTIONAL FLOW RESERVE MEASUREMENTS IN CORONARY STENOSES OF INTERMEDIATE SEVERITY
M. Ozdemir, T. Timurkaynak, M. Cemri, B. Boyaci, R. Yalcin, A. Cengel, O. Dortlemez, H. Dortlemez, Ankara, Turkey
26  CORRECTED TIMI FRAME COUNT AND ITS RELATÝON TO MYOCARDIAL FRACTIONAL FLOW RESERVE IN THE INTERMEDIATE CORONARY ARTERY LESION EVALUATION
T. Timurkaynak, B. Boyaci, M. Ozdemir, M. Cemri, R. Yalcin, A. Cengel, O. Dortlemez, Ankara, Turkey
27  EVIDENCE OF TRIMETAZIDINE-MEDIATED IMPROVEMENT OF CORONARY MICROCIRCULATION: A 201TL SCINTIGRAPHIC STUDY IN PATIENTS WITH CHRONIC STABLE ANGINA
E. Di Girolamo, F. Potere, G. Ranalli, P. Sabatini, L. Leonzio, C. Di Iorio, Chieti, Italy
28  STUDIES ON IMPAIRMENT OF CORONARY MICROCIRCULATION IN THE INFARCT RELATED ARTERY AFTER REPERFUSION THERAPY
T. Hayashi, Y. Kuga, Y. Nishida, E. Takase, Osaka, Japan
29  BASAL RELEASE OF NITRIC OXIDE IN VASOSPASTIC ANGINA PECTORIS
Y. Nishida, T. Hayashi, K. Nasu, T. Fukushima, T. Nakai, A. Fujii, Y. Kuga, Ikoma-gun, Japan
30  IMPAIRMENT OF CORONARY FLOW VELOCITY RESERVE IN PATIENTS WITH SYNDROME X SEEMS TO BE DUE TO ELEVATION OF BASELINE FLOW VELOCITY
J. Qian, J. Ge, H. Chen, D. Baumgart, M. Haude, S. Sack, R. Erbel, Shanghai, China
31  EFFECT OF INTRA-AORTIC COUNTERPULSATION (IACP) ON THE IMPLANTED INTERNAL THORACIC ARTERY FLOW
N. Shapira, S. Silberman, G. Falkowski, O. Merin, I. Dzigibaker, D. Bitran,
Jerusalem, Israel
32  INFLUENCE OF MOXONIDINE MONOTHERAPY AND MOXONIDINE WITH MELATONIN THERAPY ON CIRCULATION VARIABLES AND THEIR CIRCADIAN RHYTHMS IN HYPERTENSIVE PATIENTS
R.M. Zaslavskaya, F. Komarov, A. Shakirova, Moscow, Russia
56  FUNCTIONAL EVALUATION OF ANGIOGRAPHICALLY NORMAL SAPHENOUS VEIN GRAFTS
A. Ciszewski, J. Przyluski, P. Szmaus, W. Piotrowski, Warsaw, Poland
P414:  VENTRICULAR FUNCTION, HEART FAILURE I
33  FAILURE OF CARDIAC TROPONIN I AND T TO REFLECT SEVERITY OF HEART FAILURE AND TO PREDICT ADVERSE OUTCOMES IN CHRONIC ISCHEMIC AND NON-ISCHEMIC HEART FAILURE
J.P. Bertinchant, N. Combes, A. Polge, A.M. Boularan, F. Raczka, P. Fabbro-Peray, M.C. Eberle, G. Baudin, M. Laprade, P.O. Kotzki, P. Messner-Pellenc, J.M. Davy, Montpellier, France
34  ACUTE EFFECTS OF LIRIODENINE ON LEFT VENTRICULAR-ARTERIAL COUPLING IN WISTAR RATS: PRESSURE-VOLUME ANALYSIS
K-C. Chang, Y-I. Peng, Y-Z. Tseng, M-J. Su, Taipei, Taiwan-R.O.C.
35  IS APOPTOSIS THE EXPLANATION OF SKELETAL MUSCLE HYPOTHESIS IN CHRONIC HEART FAILURE?
G. Filippatos, C. Kanatselos, B. Vougas, D.D. Manolatos, A. Sideris, D. Kardara, B.A. Krokos, B.D. Uhal, F. Kardaras, Athens, Greece
36  DILATED MYOCARDIOPATHY - LONG TERM PROGNOSTIC VALUE OF ECHOCARDIOGRAPHIC INDEXES
R. Rasteiro, L. Branco, R. Soares, A. Abreu, P. Bico, S. Martins, C. Silveira, A. Agapito, L. Sousa, C. Salomao, A.M. Antunes, Miraflores, Portugal
37  EFFECTS OF CORONARY ARTERY BYPASS SURGERY ON DIASTOLIC PARAMETERS OF LEFT VENTRICLE IN TYPE II DIABETIC AND NON-DIABETIC PATIENTS
A. Sagcan, S.K. Celik, L.H. Can, S. Payzin, A. Altintig, H. Kultursay, Izmir, Turkey
38  EFFECTS OF REVASCULARIZATION ON LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC PARAMETERS IN TYPE II DIABETIC PATIENTS IN EARLY PERIOD
A. Sagcan, S.K. Celik, M. Sen, T. Karacoban, L.H. Can, S. Payzin, A. Altintig, H. Kultursay, Izmir, Turkey
39  LEFT VENTRICULAR REMODELING PROGNOSIS FOR PATIENTS WITH REGIONAL POSTINFARCTION DYSFUNCTIONS
E. Vataman, Chisinau, Moldova
40  THE IMPACT OF INTENSIVE CARE PROGRAM ON MANAGEMENT OF CHRONIC HEART FAILURE
E.R. Perna, S.M. Macin, J.P. Cimbaro Canella, C.D. Tacchi, N.G. Rios, P.M. Alvarenga, V. Mayans, Corrientes, Argentina
P415:  PROGNOSTIC ASPECTS
41  IS QRS WIDENING WITH FLECAINIDE DURING STRESS TEST IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION A PREDICTOR OF LATE SUDDEN EVENTS? EXPERIENCE IN 147 PATIENTS
K.G. Adamian, A.V. Astvatsatrian, A.L. Chilingarian, A.Z. Garibjanian, T.R. Astvatsatrian, S.I. Vardanian, Yerevan, Armenia
42  PREDICTION OF CARDIAC MORTALITY IN NONISCHEMIC DILATED CARDIOMYOPATHY BY EVALUATION OF SIGNAL-AVERAGED ELECTROCARDIOGRAM AND SIMPLE ECHO-DOPPLER INDICES
G. Kazianis, C. Michaelidis, C. Tsoukala, S. Feggos, A. Goumizakis, P. Economopoulos, A. Economou, Athens, Greece
43  ARE WE MANAGING WOMEN WITH NON ST ELEVATION ACUTE CORONARY SYNDROMES EQUALLY TO MEN? RESULTS FROM THE PROSPECTIVE REGISTRY OF ACUTE CORONARY SYNDROMES IN THE UNITED KINGDOM (PRAIS-UK)
M. Shibata, J.R. Collinson, A. Bakhai, M.D. Flather, R. Mattu, J. Adgey, K.A.A. Fox, London, UK
44  ARE WE DELIVERING GOOD CLINICAL PRACTICE TO ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROMES? RESULTS FROM THE PROSPECTIVE REGISTRY OF ACUTE ISCHAEMIC SYNDROMES IN THE UNITED KINGDOM (PRAIS-UK)
M. Shibata, J.R. Collinson, A. Bakhai, M.D. Flather, K.A.A. Fox, I. Findlay, E.A. Rodrigues, London, UK
45  PROGNOSTIC SIGNIFICANCE OF QT DISPERSION IN MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
B. Sredniawa, A. Musialik-Kydka, P. Chodor, S. Pasyk, Zabrze, Poland
46  BALLOON ANGIOPLASTY FOR INFARCT-RELATED LESIONS RECEIVED THROMBOLYSIS ON ACUTE PHASE
K. Takemoto, H. Horibe, T. Hidaka, S. Shimizu, M. Watarai, Y. Shiga, F. Takatsu, Anjo, Japan
47  CORRELATION BETWEEN ERYTHROCYTE SEDIMENTATION RATE AND C-REACTIVE PROTEIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES
L.A. Wu, S.-L. Tan, J.J. Liu, R.S. Wright, S.L. Kopecky, P.J. Santrach, B.A. Williams, R.L. Frye, Rochester MN, USA
48  NON INSULIN DEPENDENT DIABETES MELLITUS IMPACT ON ACUTE ISCHEMIC SYNDROMES PATIENTS PROGNOSIS EVALUATED IN 5 YEARS FOLLOW UP
A. Felix, A. Sousa, M. Monteiro, J. Galvao, V. Azevedo, V. Mendes, J.M. Santos, J.S. Nunes, A. Aleixo, Lisbon, Portugal
49  MICROALBUMINURIA: A POTENT MARKER FOR CARDIOVASCULAR END ORGAN DAMAGE IN NIDDM
P.J.V. Sanvicente, J.L. Manalo, H.B. Calleja, Manila, Philippines
P416:  VENTRICULAR FUNCTION, HEART FAILURE II
51  ELEVATED FIBRINOGEN IN ACUTE CARDIOGENIC PULMONARY EDEMA: ETIOLOGY IN FOCUS
G. Koracevic, S. Andrejevic, R. Jankovic, S. Milocevic, L. Pesic, E. Cvetkovic, S. Stojanovic, S. Iric, M. Randjelovic, B. Randjelovic, S. Salinger, D. Djordjevic, K. Chouliaris, Nis, Yugoslavia
52  EXERCISE INTERVAL TRAINING IN CHD PATIENTS WITH LEFT VENTRICULAR IMPAIRMENT
K. Mazurek, S. Rudnicki, Warsaw, Poland
53  THE INFLUENCE OF EXERCISE TRAINING ON ERGOSPIROMETRY PARAMETERS IN PATIENTS WITH CONGESTIVE HEART FAILURE SYMPTOMS
K. Mazurek, S. Rudnicki, Warsow, Poland
54  EFFECTS OF INTERVENTRICULAR SEPTUM AND VENTRICULAR FREE WALL MOTION ABNORMALITIES ON LEFT AND RIGHT VENTRICULAR FUNCTION AFTER A FIRST MYOCARDIAL INFARCTION
E. Macieira Coelho, M. Alves, G. Cantinho, I. Dionisio, A. Gouveia, Lisbon, Portugal
55  EVOLUTION OF DIASTOLIC DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND PRESENCE OF ANTIPHOSPHOLIPID ANTIBODIES
I. Moyssakis, M. Tektonidou, V. Vasiliou, K. Boki, D. Xanthis, M. Kyriakidis, Athens, Greece
 

This site was developed by .